Active Ingredient: sulfasalazine
Azulfidine is used for treating ulcerative colitis. It is also used to increase the time between attacks of ulcerative colitis.
Azulfidine EN-tabs (sulfasalazine delayed release tablets) is an anti-inflammatory agent and immunomodulatory agent used to treat moderate to severe ulcerative colitis. Azulfidine is also used to treat rheumatoid arthritis in children and adults who have received other arthritis medications without successful treatment of symptoms. Azulfidine is available in generic form
Our Azulfidine EN-tabs (sulfasalazine delayed release tablets) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
This is not a complete list of side effects and others may occur. Call your doctor for medical advice about side effects. You may report side effects to FDA at 1-800-FDA-1088.
Sulfasalazine may cause your skin or urine to turn yellowish-orange. This is a harmless effect.
If you have diabetes, sulfasalazine may affect your blood sugar. Check your levels often, and talk to your doctor before changing any doses of your diabetes medicines.
Continue to take sulfasalazine even if you feel well. Don’t stop taking the medicine without first talking to your doctor.
Keep all appointments with your healthcare provider and laboratory while taking sulfasalazine. Your physician may want to perform frequent tests to check your body’s response to the drug.
Sulfasalazine may make your skin more sensitive to sunlight. Avoid any unnecessary sun exposure, and wear protective clothing and sunscreen while outdoors.
The medicine may also cause drowsiness or dizziness. Be cautious when driving or performing any task that requires alertness.